400-900-4166

Recombinant Human VEGFC/Flt4 ligand/Flt4-L/vascular endothelial growth factor C,BR

Recombinant Human VEGFC/Flt4 ligand/Flt4-L/vascular endothelial growth factor C

(订货以英文名为准)
产品编号:AC81330 品牌:Acmec
中文名称:
Recombinant Human VEGFC/Flt4 ligand/Flt4-L/vascular endothelial growth factor C
英文名称:
Recombinant Human VEGFC/Flt4 ligand/Flt4-L/vascular endothelial growth factor C
保存条件:
-20°C

产品属性 Product Attributes

基本信息

别名: Vascular Endothelial Growth Factor C;VEGF-C;Flt4 Ligand;Flt4-L;Vascular Endothelial Growth Factor-Related Protein;VRP;VEGFC
规格: 10ug ; 50ug ; 500ug ; 1mg
外观(性状): Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 8.0.
纯度: ≥95% as determined by reducing SDS-PAGE.
储存条件: Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months.

产品信息

背景说明: Vascular Endothelial Growth Factor (VEGF)-C is a member of the VEGF family,a group of polypeptide growth factors which play key roles in the physiology and pathology of many aspects of the cardiovascular system,including vasculogenesis,hematopoiesis,angiogenesis and vascular permeability.While VEGFC is homologous to other members of the VEGF/PDGF family,it contains the C-terminal propeptide which has an unusual structure with tandemly repeated cysteine-rich motifs.Upon biosynthesis,VEGFC is secreted as a non-covalent momodimer in an anti-parellel fashion.VEGF signalling in endothelial cells occurs through three tyrosine kinase receptors (VEGFRs) expressed by endothelial cells and hematopoietic precursors,and VEGF-C is a ligand for two receptors,VEGFR-3 (Flt4),and VEGFR-2.It is indicated that VEGFC undergoes a complex proteolytic maturation generating a variety of processed secreted forms with increased activity toward VEGFR-3,but only the fully processed form could activate VEGFR-2.VEGFC may function in angiogenesis of the venous and lymphatic vascular systems during embryogenesis,and also in the maintenance of differentiated lymphatic endothelium in adults.Knockout of the VEGF-C gene is embryonic lethal late in development,and although cells differentiate into the lymphatic lineage,they fail to sprout and form lymphatic vessels.Inactivation of a single VEGF-C allele results in the development of cutaneous lymphatic hypoplasia and lymphedema.
来源: Human Cells

其它标识

溶剂: Always centrifuge tubes before opening.Do not mix by vortex or pipetting.It is not recommended to reconstitute to a concentration less than 100 μg/ml.Dissolve the lyophilized protein in distilled water.Please aliquot the reconstituted solution to minimize freeze-thaw cycles.
内毒素: Less than 0.1 ng/ug(1 EU/ug)as determined by LAL test.

产品介绍 Product Introduction

暂无数据

注意事项 Considerations

1.本产品仅供科研使用。请勿用于医药、临床诊断或治疗,食品及化妆品等用途。请勿存放于普通住宅区。
2.为了您的安全和健康,请穿好实验服并佩戴一次性手套和口罩操作。
3.实验结果可由多种因素影响,相关处理只限于产品本身,不涉及其他赔偿。

危化品级别:
关于的化合物详细属性等信息,点击“
技术资料
DATA SHEET
历史浏览记录
​Copyright ◎ 2018 ACMEC-E.COM-版权所有,未经授权禁止拷贝本站资料,如有违反,将追究法律责任
上海吉至生化科技有限公司
沪公网安备31012002005909号   沪ICP备18007380号-1
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用。
危险品化学品经营许可证    营业执照(三证合一)